These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2108893)

  • 1. Interferon treatment of chronic non-A, non-B (HCV) hepatitis: the saga continues.
    Koff RS
    Gastroenterology; 1990 May; 98(5 Pt 1):1384-6. PubMed ID: 2108893
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B hepatitis: interim results of a randomized controlled open study.
    Weiland O; Schvarcz R; Wejstål R; Norkrans G; Foberg U; Frydén A
    Scand J Infect Dis; 1989; 21(2):127-32. PubMed ID: 2499037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.
    Omata M; Ito Y; Yokosuka O; Imazeki F; Uchiumi K; Takano S; Hosoda K; Ohto M
    Dig Dis Sci; 1989 Mar; 34(3):330-7. PubMed ID: 2493364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB; Hollinger FB
    Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-interferon and post-transfusion NANB hepatitis.
    Craxì A; Di Marco V; Volpes R; Bruno R; Palazzo U; Maggio A
    Lancet; 1989 Feb; 1(8634):391-2. PubMed ID: 2563552
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.
    Jacyna MR; Brooks MG; Loke RH; Main J; Murray-Lyon IM; Thomas HC
    BMJ; 1989 Jan; 298(6666):80-2. PubMed ID: 2493302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha interferon treatment of chronic non-A, non-B hepatitis caused by intravenous gammaglobulin.
    Schvarcz R; Weiland O; Glaumann H
    Scand J Infect Dis; 1988; 20(2):231-2. PubMed ID: 2456609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic type C hepatitis with alpha interferon.
    Hoofnagle JH; Di Bisceglie AM
    Semin Liver Dis; 1989 Nov; 9(4):259-63. PubMed ID: 2513647
    [No Abstract]   [Full Text] [Related]  

  • 9. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
    Vento S; Di Perri G; Garofano T; Cosco L; Concia E; Ferraro T; Bassetti D
    Lancet; 1989 Oct; 2(8668):926. PubMed ID: 2571851
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon for chronic hepatitis C in patients cured of malignancy.
    Cesaro S; Rossetti F; De Moliner L; Crivellaro C; Zanesco L; Bortolotti F
    Eur J Pediatr; 1994 Sep; 153(9):659-62. PubMed ID: 7957425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.
    Davis GL; Balart LA; Schiff ER; Lindsay K; Bodenheimer HC; Perrillo RP; Carey W; Jacobson IM; Payne J; Dienstag JL;
    N Engl J Med; 1989 Nov; 321(22):1501-6. PubMed ID: 2509916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of non-A, non-B hepatitis with interferon--effectiveness and administration methods].
    Omata M
    Nihon Rinsho; 1988 Dec; 46(12):2676-80. PubMed ID: 3149341
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphoblastoid interferon in chronic hepatitis C patients, 'non-responders' to recombinant interferon-alpha (rIFN-alpha).
    Cimino L; Citarella C; Nardone G; Budillon G
    J Hepatol; 1992 Mar; 14(2-3):419-20. PubMed ID: 1500709
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon alpha-2a treatment of 26 patients with chronic non-A non-B hepatitis. Predictive factors of response].
    Lunel-Fabiani F; Guivarch P; Valla D; Grippon P; Marques MA; Huraux JM; Le Charpentier Y; Levy VG; Bousquet O; Opolon P
    Gastroenterol Clin Biol; 1990; 14(10):705-9. PubMed ID: 2124569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
    Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
    Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials.
    Tinè F; Magrin S; Craxì A; Pagliaro L
    J Hepatol; 1991 Sep; 13(2):192-9. PubMed ID: 1835989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
    Hoofnagle JH; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Peters M; Waggoner JG; Park Y; Jones EA
    N Engl J Med; 1986 Dec; 315(25):1575-8. PubMed ID: 3097544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophilia.
    Lee CA; Kernoff PB; Karayiannis P; Thomas HC
    Br J Haematol; 1989 Jun; 72(2):235-8. PubMed ID: 2503026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy.
    Thomson BJ; Doran M; Lever AM; Webster AD
    Lancet; 1987 Mar; 1(8532):539-41. PubMed ID: 2434816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retreatment with recombinant interferon-alpha in patients with chronic hepatitis C.
    Marcellin P; Pouteau M; Boyer N; Castelnau C; Erlinger S; Benhamou JP
    J Infect Dis; 1993 Mar; 167(3):780-1. PubMed ID: 8440950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.